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Abstract 
Pseudomonas fluorescens lipase-catalyzed transesterification of 2-hydroxymethyl-1,4-
benzodioxanes of different substitution patterns were studied in the presence of vinyl acetate in 
organic solvents. The influence of structural features on the conversion and enantioselectivity is 
discussed and it is shown that the presence of a C-3 methyl or aryl substituent significantly 
hinders the binding of the substrate to the active site of the enzyme. Thus, with a bulky C-3 
substituent no transesterification of the 2-hydroxymethyl group could be observed. 
 
Keywords: Pseudomonas fluorescens, kinetic resolution, 1,4-benzodioxanes 
 
 
 
Introduction 
 
The 1,4-benzodioxane moiety has been widely used in the design of therapeutic agents with α-
adrenergic blocking1-6, antigrastic7, spasmolytic8, antipsychotic9, anxiolytic10 and 
hepatoprotective11 properties. The biological activity of these compounds is, however, 
considerably influenced by the absolute configuration of the 1,4-benzodioxane unit.12 Recently, 
the lipase from Pseudomonas fluorescens (PsfL)-catalyzed kinetic resolution of 2-
hydroxymethyl-1,4-benzodioxanes was considered a convenient method for the resolution of 
their enantiomers.13-18 As a continuation of our ongoing research on the synthesis of naturally 
occurring flavanolignans possessing 1,4-benzodioxane moiety and significant hepatoprotective 
Issue in Honor of Prof Csaba Szantay                                                                         ARKIVOC 2008 (iii) 200-210 
ISSN 1551-7012                                                       Page 201                                                       ©ARKAT USA, Inc. 
activity,19,20 it seemed promising to use this method for the preparation of dextrorotatory 
enantiomers of 1,4-benzodioxane 6- or 7 carbaldehyde derivatives (3, 4), which may serve as 
suitable building blocks for the synthesis of hepatoprotective (2S,2’R,3’R)-silandrin (1) and 
(2S,2’R,3’R)-isosilandrin (2), respectively, isolated from the white-flowered variant of Silybum 
marianum.21,22 (Scheme 1). The synthesis of these natural products in racemic form [(±)-1, -2] 
had already been reported19,22 starting from the readily available racemic aldehydes 3 and 4,23 
respectively. 
 
 
 
Scheme 1 
 
 
Results and Discussion 
 
According to our earlier results,13 the lipase-catalyzed transesterification of (±)-3 and -4 using 
vinyl acetate (VA) as an irreversible acyl donor has been carried out in dry dioxane at room 
temperature in the presence of Pseudomonas fluorescens (PsfL) (Scheme 2). The progress of the 
reaction was monitored by TLC, which surprisingly showed that no transformation occurred 
even after 168 hours (Table 1, entries 1 and 2). The use of different solvents of various dielectric 
constants and dipole moments (entries 3-6) did not help the situation either. Similarly, the 1,4-
benzodioxane derivative 5, possessing no formyl group on the aromatic ring, did not show 
transformation at all (entry 7). Moreover, it should be also noted that the lipase from 
Pseudomonas cepacia (PCL) did not catalyze the transesterification of these compounds [(±)-3-
5, entries 8 and 10] either, although this enzyme could be used successfully for the kinetic 
resolution of hindered 3-hydroxymethyl-2-aryl-2,3-dihydrobenzo[b]furans.24 Since 2-
hydroxymethyl-1,4-benzodioxane [(±)-6] could be resolved efficiently by PsfL (entry 11),13 the 
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above results clearly indicate that it is the presence of the bulky C-3 aryl group that hinders the 
binding of the substrates (±)-3-5 to the active site of the enzyme.  
 
 
 
Scheme 2 
 
 The role of this steric hindrance inflicted by the C-3 substituent was also proved by 
transesterification of (±)-7 possessing a readily accessible C-7 hydroxymethyl group besides the 
sterically hindered C-2 one. In accordance with our expectation, its enzyme-catalyzed 
transesterification took place exclusively at the C-7 hydroxymethyl group and after 154 h, it 
afforded the monoacetate derivative (±)-8 with 100% conversion which could also be obtained 
by a simple acetolysis of (±)-7 carried out at the boiling point of acetic acid. This result also 
clearly indicated that the presence of a bulky group at C-3, such as an aryl one, makes the C-2 
hydroxymethyl group unable to fit the active site of the enzyme, and thus the readily available C-
7 hydroxymethyl group is acylated preferably, which process is certainly not enantioselective. 
When the C-3 aryl group was replaced by a smaller one such as a methyl group [(±)-9], the 
transesterification took place sluggishly with low enantioselectivity (entry 12; 168 h, 25% 
conversion and 23% ee), as the C-2 hydroxymethyl group became more available for the active 
site of the enzyme.  
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Table 1. Enzymatic resolution of 2-hydroxymethyl-1,4-benzodioxanes 
Entry Lipase
a 
(amount)b Substr. 
Solventc 
(Dk, µ)d 
Time 
h 
Conv.e 
% 
(-)-Alcohol 
%eef,conf.g 
(+)-Acetate 
%ee, conf. E
h 
1 PsfL (523) 3 
dioxane 
(2.2; 0.4) 168 -    
2 PsfL (523) 4 dioxane 168 -    
3 PsfL (1046) 3 
DCM 
(8.9; 1.5) 168 -    
4 PsfL (1046) 4 DCM 168 -    
5 PsfL (1046) 3 
THF 
(7.4; 1.1) 168 -    
6 PsfL (1046) 4 THF 168 -    
7 PsfL (523) 5 dioxane 168 -    
8 PCL (523) 3 dioxane 168 -    
9 PCL (523) 4 dioxane 168 -    
10 PCL (523) 5 dioxane 168 -    
11 PsfL (523) 6 dioxane 13.5 62 99.5 S -R 22.6
12 PsfL (523) 9 dioxane 168 25 23 S 12 R 1.5 
13 PsfL (523) 10 dioxane 97 48 73 S 57 R 7.7 
14 PsfL (523) 11 dioxane 97 45 65 S 75 R 14 
15 PsfL (523) 12 dioxane 18 45 98 S -R - 
16 PsfL  13 
DCM 
sat. with 
H2O 
144 50 >98 S 78 R 18.9
17 PsfL (1046) 14 dioxane 214 45 71 S 79 R 14 
18 PsfL (523) 15 dioxane 214 52 52 S 75 R 11 
aEnzymes were commercially available (Fluka). bIn units of enzyme per mmol of substrate. cAll 
the solvents were anhydrous and contained 44 mmol vinyl acetate/mmol substrate. DCM: 
dichloromethane. dDielectric constant and dipole moment (Debye) values were taken from Ref. 
25. eConversion degrees were calculated from the yields of the isolated products obtained by 
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preparative TLC. The reaction was carried out at room temperature. fThe enantiomeric excess 
was determined by measuring the optical rotation in chloroform (c = 0.2-1 g/100mL) at sodium 
D-line and compared with those published in the literature or by HPLC using Chiracel OJ 
column as chiral stationary phase. gAbsolute configuration of compound was determined by CD 
measurements based on our chiroptical rule27 and chemical correlation as well. hCalculated 
according to Ref. 26. 
 
 
 
 
Scheme 3 
 
 In order to study further the topology of the active site of the PsfL enzyme and the effect of 
structural features on the selectivity, kinetic resolution of further 2-hydroxymethyl-1,4-
benzodioxane derivatives (±)-10-19 were also performed and compared with that of 2-
hydroxymethyl-1,4-benzodioxane [(±)-6]. Kinetic transesterification of racemic aldehydes 10 
and 11 was performed under the same conditions as used previously for (±)-6 (entry 11).13 The 
transesterification took place significantly slower in both cases than that of (±)-6 to result in 
levorotatory alcohols (2S)-10 and (2S)-11 with 73% and 65% enantiomeric excesses, 
respectively (entries 13 and 14). These results revealed that the presence of a C-6 or C-7 formyl 
group significantly decreased the chiral recognition of the enzyme. Interestingly, replacement of 
the formyl group by a bulkier acetophenone moiety [(±)-11→ (±)-12] caused a remarkable 
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enhancement in both the reaction rate and the enantioselectivity (entry 15). Thus, with 45% 
conversion, determined by HPLC after 18 hours, the enantiomeric excess of the recovered 
alcohol [(−)-(2S)-12] was 98%. Recently, Ennis and Ghazal also reported an efficient application 
of the PsfL enzyme in the kinetic resolution of racemic flesinoxane [(±)-13] possessing a bulky 
side-chain at C-5 (entry 16).15 Interestingly, the presence of a C-6 or C-7 (E)-3-ethoxy-3-oxo-1-
propenyl side chain in (±)-14 and (±)-15, decreased the chiral recognition (entry 17 and 18) of 
the enzyme compared to that of (±)-12 (entry 15).  
 
Table 2. PsfL catalyzed transesterification of 16-19 
Entry Substr. 
Time 
h 
Conv.a 
% 
(-)-Diol 
prod., ee%b, 
conf.c 
(-)-Monoacetate 
prod., (ee%), 
conf. 
(+)-Diacetate 
prod., (ee%), 
conf. 
Ed 
1 16 167 67 16 (11) S 18 (75) S 18 Ac (67)  
2 17 167 66 17 (33) S 19 (62) S 19 Ac (87)  
3 18 167 50  18 (76) S 18 Ac (61) 9.2 
4 19 167 55  19 (92) S 19 Ac (59) 15 
 
 In compounds (±)-16 and (±)-17 (Scheme 3), there are two competing hydroxymethyl groups 
for acetylation and only the acetylation of the C-2 one is expected to occur enantioselectively. 
The TLC monitoring of their kinetic transesterification showed that besides the remaining 
levorotatory alcohols [(-)-(2S)-16, -17], two products were formed at 66-67% conversion, which 
could be separated by preparative TLC. The structure elucidations of these compounds, based on 
their NMR data and chemical correlation with their corresponding aldehydes 11 and 10, clearly 
showed that (−)-(2S)-18 and -19 monoacetates and (+)-(2S)-18Ac and -19Ac diacetates were 
produced (Table 2, entries 1 and 2). Their optical purities showed a good agreement with those 
prepared by PsfL catalyzed kinetic resolution of racemic monoacetates [(±)-18, 19] (entries 3 and 
4). The latter compounds were obtained from (±)-16 and (±)-17 in a similar manner as in the case 
of (±)-8. Moreover the low optical purity of the remained levorotatory alcohols [(-)-(2S)-16, ee% 
= 11; (-)-2S-17, ee% = 33] has clearly showed that the first transesterification took place 
exclusively on the aromatic hydroxymethyl group without significant enantioselectivity [(±)-16 
→ (±)-18, (±)-17 → (±)-19]. Thus, levorotatory monoacetates [(−)-(2S)-18 and (−)-(2S)-19] of 
high optical purity [ee% = 76 and 92, respectively] could be obtained during the second 
transesterification step of the C-2 hydroxymethyl group due to the known R enantiopreference of 
the PsfL active site.13-18 This result has again underscored that the binding of the more accessible 
aromatic C-6 or C-7 hydroxymethyl group to the PsfL active site is preferred to the binding of 
the C-2 hydroxymethyl group which is presumably hindered by the non-planar heterocyclic ring.  
 As a summary, we have shown that Pseudomonas fluorescens lipase-catalyzed acetylation 2-
hydroxymethyl-1,4-benzodioxanes possessing no substituent at C-3 using vinyl acetate as 
acylating agent provides the corresponding levorotatory alcohols of (2S) absolute configuration 
in an acceptable chemical yield (40-50%) and enantiomeric purity (ee% > 65), since the (R) 
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enantiomer reacted faster in all cases. Moreover it has been also shown that the formation of the 
enzyme-substrate complex (ES) is not considerably influenced by the substituents of the 
aromatic ring, having different steric effect and polarity. However, the replacement of the 3-H to 
a methyl group hinders the formation of the enzyme-substrate complex, resulting in low 
conversion and enantioselectivity. Interestingly, with a C-3 substituent larger than a methyl 
group, the ES complex does not form at all. Interpretation of our experimental results is in 
progress by using computer-assisted molecular design (CAMD) and the X-ray structure of 
PfsL.30 
 
 
Experimental Section 
 
General Procedures. Column chromatography was performed on silica gel (Merck 60, 70-230 
mesh). The thin layer chromatography was performed on aluminum backed TLC plates of silica 
gel 60 F254 (Merck, 0.2 mm) with the indicated eluent. The HPLC was performed on Chiralcel 
OD column (250x4.6 mm, 10 µm, analytical column, Daicel Chemical Industries, LTD.) with 
Jasco type HPLC system: Jasco PU-980 HPLC Pump, Jasco MD-910 Multiwavelength detector. 
NMR spectra were recorded on a Bruker AM 360 (360.13 MHz for 1H, 90.03 MHz for 13C) 
spectrometer. Chemical shifts (δ) are given from internal CHCl3 (7.26) for 1H NMR and (77.00) 
for 13C NMR. Coupling constants (J in Hz) are accurate to ±0.2 Hz for 1H. Elemental analyses 
(C, H) were conducted using the Carlo Erba 1106 EA instrument. IR spectra were recorded on an 
Perkin Elmer 16 PC FTIR spectrometer and absorption bands presented in cm-1. CD spectra were 
obtained with a Jasco-810 spectropolarimeter in Sharlau Spectosolv grade solvents at room 
temperature. The tested racemic compounds 3-6,22 9-13,19, 27 1428 and 1529 were prepared as 
described in the literature. The compounds characterized below have not been reported yet in the 
literature even in a racemic form. 
 
(2R*,3R*)-Bis-2,7-hydroxymethyl-3-(4-hydroxy-3-methoxyphenyl)-1,4-benzodioxane [(±)-7]. 
To a solution of (±)-322 (1 mmol) in dry ethanol (5 mL) NaBH4 (1 mmol) was added and stirred 
for 2 hours at ambient temperature. The reaction mixture was neutralized with 10% HCl solution 
and was extracted with dichloromethane (2x25mL). The organic phase was dried (MgSO4) then 
evaporation of the solvent resulted in (±)-7 (58%), mp: 124-126 °C as white crystals. 
IR (KBr) ν (cm-1): 3454, 2941, 1603, 1517, 1216, 1141. 1H-NMR: δ 3.50-3.65 (2H, m, 3-
CH2OH), 3.91 (3H, s, OMe), 4.02 (1H, m, H-3), 4.60 (2H, s, 6-CH2OH), 4.90 (2H, d, J = 14Hz, 
H-2), 5.79 (1H, s, ArOH), 6.85-7,00 (6H, m, ArH). 13C-NMR: δ 55.9 (OMe), 63.6 (2-CH-
CH2OH), 65.3 (7-C-CH2OH), 88.1 (3-CH-Ar), 89.5 (2-CH-CH2OH), 108.8 (8-C, 2”-C, Ar), 
114.4 (5-C, 5”-C, Ar), 119,4 (6-C, 6”-C, Ar), 128.9 (1”-C, Ar), 132.0 (7-C, Ar), 145.6 (4”-C), 
146.0 (3”-C), 146.7 (8a-C), 146.8 (5a-C). Anal: calcd. for C17H18O6 (318.32): C, 64.14; H, 5.70. 
Found C, 64.12; H, 5.72. 
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(2R*,3R*)-7-Acetoxymethyl-2-hydroxymethyl-3-(4-hydroxy-3-methoxyphenyl)-1,4-benzo-
dioxane [(±)-8]. To a solution of (±)-7 (0.2 mmol) in glacial acetic acid (1 mL) was refluxed for 
2 hours the it was diluted with water (10 mL) and extracted with ethyl acetate (2x10 mL). The 
organic layer was washed with saturated NaHCO3 solution (2x10 mL) and brine (1x10 mL). The 
organic phase was dried (MgSO4) then the solvent was evaporated. The residue was purified by 
column chromatography (chloroform: methanol= 20:1) to give (±)-8 (61%) as pale yellow oil.  
IR (KBr) ν (cm-1): 3453, 2940, 1605, 1516, 1215, 1142. 1H-NMR: δ 2.08 (3H, s, 7-CH2OAc), 
3.57 (2H, m, 3-CH2OH), 3.91 (3H, s, OMe), 4.02 (1H, m, H-3), 4.92 (2H, d, J = 14Hz, H-2), 
5.02 (2H, s, 7-CH2OAc), 5.75 (1H, s, ArOH), 6.91-7.00 (6H, m, ArH). 13C-NMR: δ 20.5 (CO-
CH3), 55.8 (OMe), 63.8 (2-CH-CH2OH), 65.5 (7-C-CH2OAc), 88.3 (3-CH-Ar), 89.8 (2-CH-
CH2OH), 109.8 (8-C, 2”-C, Ar), 114.6 (5-C, 5”-C, Ar), 119,2 (6-C, 6”-C, Ar), 130.1 (1”-C, Ar), 
132.5 (7-C, Ar), 145.8 (4”-C), 146.2 (3”-C), 146.7 (8a-C), 146.5 (5a-C), 170.6 (CO-CH3). Anal: 
calcd. for C19H20O7 (360.36): C, 63.33; H, 5.59. Found C, 63.35; H:5.61. 
a) A solution of (±)-7 (0.15 mmol) in dry dioxane (5 mL) was treated with vinyl acetate (1 mL, 
22 mmol) and the lipase Pseudomonas fluorescens (50 mg). The suspension was stirred at room 
temperature and after 154 hours (conv.=100%) the usual work up gave (±)-8. 
 
(2R*)-2,6-Bis(hydroxymethyl)-1,4-benzodioxane [(±)-16] and (2R*)-2,7-Bis(hydroxymethyl)-
1,4-benzodioxane [(±)-17]. To a solution of (±)-11 or (±)-10 (5.2 mmol) in dry ethanol (30 mL) 
NaBH4 (5.2 mmol) was added and stirred for 2 hours at ambient temperature. The reaction 
mixture was neutralized with 10% HCl solution and the product was extracted with 
dichloromethane (2x25mL). The organic phase was dried (MgSO4) then the evaporation of the 
solvent gave (±)-16 and (±)-17 respectively.  
(±)-16: 78%, mp: 81-83 °C, white crystals. HPLC: Chiralcel OJ, n-hexane: ethanol = 87:13, v = 
0.8 mL/min, DAD λ = 280 nm, tR = 38.71 (S-16), 42.85 (R-16) min. 
IR (KBr) ν (cm-1): 3358, 2893, 1593, 1509, 1288, 1037, 1011. 1H-NMR: δ 1.19 (1H, s, 6-
CH2OH), 1.60 (1H, s, 2-CH2OH), 3.71-3.91 (2H, m, H-3), 4.02 (1H, dd, J = 3.5 and 11Hz, H-2), 
4.11-4.28 (2H, m, 2-CH2OH), 4.58 (2H, s, 6-CH2OH), 6.75-6.85 (3H, m, ArH). 13C-NMR: δ 61.5 
(2-CH-CH2OH), 64.5 (3-CH-Ar), 65.3 (6-C-CH2OAc), 73.6 (2-CH-CH2OH), 116.2 (8-C, Ar), 
117.4 (5-C, Ar), 120.8 (7-C, Ar), 134.5 (6-C, Ar), 142.5 (8a-C), 142.7 (5a-C). Anal: calcd. for 
C10H12O4 (196.20): C, 61.22; H, 6.16. Found C, 61.19; H: 6.19. 
(±)-17. 65%, colorless oil. HPLC: Chiralcel OJ, n-hexane: ethanol = 87:13, v = 0.8 mL/min, 
DAD λ = 280 nm, tR = 37.22 (R-17), 39.77 (S-17) min. 
IR (KBr) ν (cm-1): 3359, 2890, 1595, 1508, 1286, 1035, 1015. 1H-NMR: δ 1.93 (1H, s, 7-
CH2OH), 3.69-3.88 (2H, m, H-3), 4.02 (1H, dd, J = 8.5 and 12Hz, H-2), 4.11-4.28 (2H, m, 2-
CH2OH), 4.35 (2H, d, J = 14 Hz, 7-CH2OH), 4.51 (1H, s, 7-CH2OH), 6.71-6.88 (3H, m, ArH). 
13C-NMR: δ 61.6 (2-CH-CH2OH), 64.8 (3-CH-Ar), 65.1 (7-C-CH2OAc), 73.4 (2-CH-CH2OH), 
116.0 (8-C, Ar), 117.2 (5-C, Ar), 120.5 (6-C, Ar), 134.3 (7-C, Ar), 142.4 (8a-C), 142.9 (5a-C). 
Anal: calcd. for C10H12O4 (196.20): C, 61.22; H, 6.16. Found C, 61.18, H: 6.16. 
(2R*)-6-Acetoxymethyl-2-hydroxymethyl-1,4-benzodioxane [(±)-18] and (2R*)-7-
Acetoxymethyl-2-hydroxymethyl-1,4-benzodioxane [(±)-19]. To a solution of 16 or 17 (2.0 
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mmol) in glacial acetic acid (0.8 mL) was refluxed for 2 hours the it was diluted with water (10 
mL) and extracted with ethyl acetate (2x10 mL). The organic layer was washed with saturated 
NaHCO3 solution (2x10 mL) and brine (1x10 mL). The organic phase was dried (MgSO4) then 
the solvent was evaporated. The residue was purified by column chromatography (toluene : ethyl 
acetate = 2:1). 
(±)-18. 61%, pale yellow oil. HPLC: Chiralcel OJ, hexane: ethanol = 87:13, v = 0.8 mL/min, 
DAD λ = 280 nm, tR = 39.20 (S-16), 42.94 (R-16) min. S-16: CD (CH3CN, 0.95 mM): λ (∆ε) 284 
(-0.18), 235 (1.39) nm. IR (KBr) ν (cm-1): 3435, 2926, 1739, 1507, 1281, 1235, 1045. 1H-NMR: 
δ 2.08 (3H, s, 6-CH2OAc), 3.87 (2H, m, 2-CH2OH), 4.06 (1H, m, H-3), 4.27 (2H, m, H-2), 4.99 
(2H, s, 6-CH2OAc), 6.87-6.99 (3H, m, ArH). 13C-NMR: δ 20.6 (CO-CH3), 61.6 (2-CH-CH2OH), 
64.8 (3-CH-Ar), 65.1 (6-C-CH2OAc), 73.4 (2-CH-CH2OH), 116.0 (8-C, Ar), 117.2 (5-C, Ar), 
120.5 (7-C, Ar), 134.3 (6-C, Ar), 142.4 (8a-C), 142.9 (5a-C). Anal: calcd. for C12H14O5 (238.24): 
C, 60.50; H, 5.92. Found C, 60.53; H, 5.90. 
(±)-19. 35%, pale yellow oil. HPLC: Chiralcel OJ, n-hexane: ethanol = 87:13, v = 0.8 mL/min, 
DAD λ = 280 nm, tR = 35.06 (R-19), 38.04 (S-19) min. S-19: CD (CH3CN, 0.68 mM): λ (∆ε) 285 
(-0.21), 234 (2.84), 216 (0.69), 207 (-0.64) nm. IR (KBr) ν (cm-1): 3433, 2924, 1736, 1508, 1282, 
1235, 1042. 1H-NMR: δ 2.10 (3H, s, 7-CH2OAc), 3.85 (2H, m, 2-CH2OH), 4.10 (1H, m, H-3), 
4.25 (2H, m, H-2), 5.00 (2H, s, 7-CH2OAc), 6.83-6.95 (3H, m, ArH). 13C-NMR: δ 20.4 (CO-
CH3), 61.5 (2-CH-CH2OH), 64.7 (3-CH-Ar), 65.3 (7-C-CH2OAc), 73.2 (2-CH-CH2OH), 116.1 
(8-C, Ar), 117.3 (5-C, Ar), 120.7 (6-C, Ar), 134.6 (7-C, Ar), 142.5 (8a-C), 142.7 (5a-C). Anal: 
calcd. for C12H14O5 (238.24): C, 60.50; H, 5.92. Found C, 60.55; H: 5.89. 
 
General procedure for the lipase-catalyzed resolution of racemic alcohols  
A solution of racemic 2-hydroxymethyl-1,4-benzodioxane (0.5 mmol) in dry dioxane 
(dichloromethane or tetrahydrofuran) was treated with vinyl acetate (1 mL, 22 mmol) and the 
lipase Pseudomonas fluorescens (10 mg). The suspension was stirred at room temperature. The 
reaction was stopped by filtration of the enzyme, the filtrate was evaporated to dryness at 
reduced pressure and the residue was separated by means of preparative TLC to give the 
corresponding (–)-S-alcohol and (+)-R acetate.  
 
Alcohols (ee%) [α]D ([c]=g/100mL, solvent) Acetates (ee%) [α]D ([c]=g/100mL, solvent) 
(–)-(S)-9 (23)* - (+)-(R)-9Ac (12)* - 
(–)-(S)-10 (73) -29.4 (0.28, CH2Cl2) (+)-(R)-10Ac (57) +21.1 (0.62, CH2Cl2) 
(–)-(S)-11 (65) -37.3 (0.22, CH2Cl2) (+)-(R)-11Ac (75) +42.6 (0.05, CH2Cl2) 
(–)-(S)-12 (98) -33.8 (0.42, CH2Cl2) (+)-(R)-12Ac (-) +43.9 (-, CH2Cl2) 
(–)-(S)-14 (71) -41.2 (1.18, CH2Cl2) (+)-(R)-14Ac (79) +55.9 (1.04, CH2Cl2) 
(–)-(S)-15 (55) -17.4 (1.37, CH2Cl2) (+)-(R)-15Ac (75) +16.5 (1.00, CH2Cl2) 
*The enantiomeric excess was determined by HPLC using Chiracel OJ column as chiral 
stationery phase. 
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